EHR-to-EDC Success in a Complex Oncology, Adaptive Platform Trial
At OpenClinica, we are especially proud of the work we are doing with the I-SPY 2 Trial, sponsored and operated...
Case Study: I-SPY 2 Delivers Personalized Oncology Treatments Faster
As we wrote in our new case study, The I-SPY series of trials are reshaping the future of personalized oncology...
Oncology Clinical Trials Case Study: I-SPY 2 & OpenClinica
Without a doubt, oncology clinical trials are among the most complex and complicated trials. Two of the primary reasons are:...
Time-Saving Triumph: Automated Study Calendaring for Clinical Trials
ICYMI, OpenClinica recently debuted market-leading automated study calendaring functionality. Our study calendaring capabilities automate scheduling and protocol visits and enable...
Why Leading Cancer Research Centers Trust OpenClinica for Oncology Trials
Oncology trials are among the most complex and challenging to conduct due to the variability in cancer types, the need...
How Different are Oncology Clinical Trials?
It’s widely known that oncology clinical trials are more complex and complicated than other trials. There are five reasons that...